Summary. The Introduction.
the first and second meiotic metaphase spindles in mouse oocyte can be decorated with a monoclonal antibody raised against MAP1 from rat brain (Rime et al., 1987) . The (Calarco-Gillam et al., 1983 ; Brinkley, 1985) , also marks the poles of barrel-shaped metaphase II of mouse oocyte. Although the mouse oocyte antigens recognized by these antibodies were not biochemically characterized, they can be considered to be spindle-associated antigens, according to cytological criteria. These antibodies have been used as a tool to analyse the cellular distribution of meiotic microtubule-associated non-tubulin proteins during germinal vesicle breakdown (GVBD) in mouse oocyte.
Estramustine phosphate, a cytotoxic anti-mitotic compound, has been shown recently to inhibit microtubule assembly in vitro by interacting with MAPs (Hartley-Asp, 1984 ; Kanje et al., 1985 ; Wallin et al., 1985!. Estramustine phosphate also produces microtubule disassembly in vivo in different cell lines . Estramustine (fig. 5c ). 5051 antibody decorated the whole metaphase spindle on cryostat sections of in vitro-matured oocytes, as reported earlier for JA2 antibody (Rime et al., 1987 fig. 5f ).
The reversibility of estramustine phosphate action was tested by incubating oocytes at GVBD (4 h of culture) for 15 min in the presence of 50 A M of estramustine phosphate. All the microtubules disappeared ( fig. 4d ). The oocytes were washed and transferred to estramustine phosphate-free medium and cultured for 2 h. They were then fixed and the cryostat sections stained with antitubulin antibody. Microtubules reappeared in the oocyte ( fig. 4f) , as in control oocytes. The microtubules which were induced to depolymerize by estramustine phosphate were therefore capable of repolymerizing after the drug was removed.
Effects of estramustine phosphate and taxol on in ovo microtubules Taxol has two effects on maturing oocytes immediately following GVBD : it causes a considerable increase in the bundling of microtubules around the chromosomes and induces the formation of asters in the cytoplasm (Rime et al., 1987) . The whole region near the chromosomes was stained by anti-tubulin antibody ( fig. 6a) . However, the way in which these drugs interact with the nuclear envelope remains unknown. Van Blerkom and Bell (1986) reported that nocodazole, a drug which depolymerizes microtubules by binding to the molecule of tubulin (Hoebeke et al., 1976) , does not inhibit GVBD in mouse oocyte but does inhibit spindle formation. We have successfully repeated this experiment. Thus, intact microtubules are not necessary for the breakdown of the nuclear envelope. In contrast, estramustine phosphate, which does not interact with the tubulin molecule itself but probably with microtubule-associated proteins (Kanje et al., 1985 ; Wallin et al., 1985) , inhibits GVBD and also induces the depolymerization of oocyte microtubules. Therefore, estramustine may not inhibit GVBD by acting on the microtubules, but by other mechanism implicating the interaction of putative MAPs and nuclear envelope breakdown.
It is interesting to note that the metaphase spindle was stained by both the anti-tubulin and the 5051 antibody. This is in contrast to the observations of Calarco-Gillam et al. (1983) (Kanje et al., 1985 ; Wallin et al., 1985) .
As noted above, the antigens recognized by JA2 and 5051 antibodies remain unknown. Although non-tubulin protein antigens recognized by both the 5051 and the JA2 antibodies are associated with microtubules after GVBD, their cellular distribution is strikingly different in prophase-maintained oocytes (figs. 3b, c) . In these oocytes the nuclear localization of MAP1-8 '1alog antigen was unchanged by estramustine phosphate treatment ( fig. 3f ). Since MAP1-analog became associated with the microtubules after GVBD, it could be involved, as already suggested, in the genesis of new MTOCs when the nuclear envelope breaks down (Sato et al., 1983 ; Bloom et al., 1984 ; Bonifacino et al., 1985 ; Ohno et al., 1985 ; Jessus et al., 1986 ; Sato et al., 1986) .
The observation that estramustine phosphate decreased the in vivo bundling action of taxol may be significant, suggesting that estramustine phosphate counteracts the in vivo taxol effect in mouse oocyte. In an earlier study (Rime et al., 1987) , we showed that JA2 antibody decorated asters induced by taxol in maturing oocytes, indicating that non-tubulin proteins might participate in the production of taxol-induced asters. A specific MAP, which remains to be identified, may thus be involved in the formation of asters after taxol treatment.
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